| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 175.26B | 178.41B | 181.47B | 160.56B | 127.32B | 118.86B |
| Gross Profit | 16.31B | 16.79B | 19.04B | 17.18B | 14.30B | 12.24B |
| EBITDA | -2.24B | -2.76B | 3.40B | 13.43B | 11.91B | 6.53B |
| Net Income | -12.57B | -13.45B | -3.93B | 1.42B | 876.00M | -6.20B |
Balance Sheet | ||||||
| Total Assets | 132.45B | 136.60B | 142.26B | 141.51B | 133.99B | 136.39B |
| Cash, Cash Equivalents and Short-Term Investments | 23.55B | 27.93B | 22.29B | 23.62B | 28.87B | 29.26B |
| Total Debt | 41.41B | 42.76B | 33.39B | 32.16B | 34.26B | 44.77B |
| Total Liabilities | 74.11B | 75.39B | 66.76B | 64.07B | 63.61B | 70.65B |
| Stockholders Equity | 50.00B | 52.53B | 66.67B | 64.23B | 57.66B | 54.00B |
Cash Flow | ||||||
| Free Cash Flow | -3.24B | -4.33B | -915.00M | -3.13B | 12.24B | 6.90B |
| Operating Cash Flow | -280.50M | 4.74B | 12.53B | 2.92B | 14.91B | 13.22B |
| Investing Cash Flow | -3.02B | -11.81B | -11.85B | -5.16B | -4.54B | -7.05B |
| Financing Cash Flow | 1.08B | 6.76B | -1.74B | -4.82B | -13.82B | 3.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥49.76B | 7.97 | 8.46% | 2.64% | -6.35% | 18.49% | |
72 Outperform | ¥75.51B | 12.87 | ― | 3.21% | 4.44% | 14.91% | |
70 Outperform | ¥56.62B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
68 Neutral | ¥91.08B | 5.17 | ― | 3.88% | -7.35% | 43.31% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥216.64B | 16.01 | ― | 4.77% | -3.71% | -51.81% | |
57 Neutral | ¥19.07B | 18.77 | ― | 3.19% | -8.99% | -62.26% |